|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/72 | (2006.01) |
| A61K 9/00 | (2006.01) | ||
| A61K 31/439 | (2006.01) | ||
| A61K 31/46 | (2006.01) | ||
| A61K 31/575 | (2006.01) | ||
| A61K 31/58 | (2006.01) | ||
| A61K 45/00 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61M 11/00 | (2006.01) | ||
| A61M 15/00 | (2006.01) | ||
| A61P 5/44 | (2006.01) | ||
| A61P 5/46 | (2006.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 11/06 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 37/08 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| C07J 31/00 | (2006.01) |
| (11) | Number of the document | 1471919 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03706683.4 |
| Date of filing the European patent application | 2003-02-04 | |
| (97) | Date of publication of the European application | 2004-11-03 |
| (45) | Date of publication and mention of the grant of the patent | 2005-08-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2003/000491 |
| Date | 2003-02-04 |
| (87) | Number | WO 2003/066063 |
| Date | 2003-08-14 |
| (30) | Number | Date | Country code |
| 0202635 | 2002-02-05 | GB |
| (72) |
BIGGADIKE, Keith GlaxoSmithKline, GB
|
| (73) |
GLAXO GROUP LIMITED,
Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN,
GB
|
| (54) | PHARMACEUTICAL COMPOSITIONS COMPRISING 17ALPHA-FURANYLESTERS OF 17BETA-CARBOTHIOATE ANDROSTANES WITH A MUSCARINIC RECEPTOR ANTAGONIST |
| PHARMACEUTICAL COMPOSITIONS COMPRISING 17ALPHA-FURANYLESTERS OF 17BETA-CARBOTHIOATE ANDROSTANES WITH A MUSCARINIC RECEPTOR ANTAGONIST |